GT Medical Technologies, Inc. announced interim findings of a multi-institutional study that demonstrates high local control for the treatment of recurrent brain metastases in patients. The findings were presented during the American Society for Radiation Oncology's (ASTRO) 65th Annual Meeting, ASTRO 2023, being held this week in San Diego, CA.
/PRNewswire/ GT Medical Technologies, Inc., a medical device company dedicated to improving the lives of patients with brain tumors, today announced interim.
GT Medical Technologies, Inc Presents New Data Further Demonstrating High Local Control for the Treatment of Recurrent Brain Metastases at the ASTRO 2023 Annual Meeting streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
GT Medical Technologies, Inc Presents New Data Further Demonstrating High Local Control for the Treatment of Recurrent Brain Metastases at the ASTRO 2023 Annual Meeting kptv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kptv.com Daily Mail and Mail on Sunday newspapers.